Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sebastian

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyJan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 MutationsFelix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
The Lancet. Infectious Diseases|October 22, 2019
Current gaps in sepsis immunology: new opportunities for translational researchIgnacio Rubio, Marcin F Osuchowski, Manu Shankar-Hari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumorsMarcus Schmidt, Birte Hellwig, Seddik Hammad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.
EMBO Molecular Medicine|August 12, 2018
Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasisHanibal Bohnenberger, Lars Kaderali, Philipp Ströbel, et al.
JCO Precision Oncology|September 11, 2020
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung CancerSebastian Michels, Carina Heydt, Bianca van Veggel, et al.
Pneumologie (Stuttgart, Germany)|October 26, 2023
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, et al.
International Journal of Molecular Sciences|April 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy AnalysisOliver Illini, Felix Carl Saalfeld, Petros Christopoulos, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyJan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 MutationsFelix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
The Lancet. Infectious Diseases|October 22, 2019
Current gaps in sepsis immunology: new opportunities for translational researchIgnacio Rubio, Marcin F Osuchowski, Manu Shankar-Hari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumorsMarcus Schmidt, Birte Hellwig, Seddik Hammad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.
EMBO Molecular Medicine|August 12, 2018
Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasisHanibal Bohnenberger, Lars Kaderali, Philipp Ströbel, et al.
JCO Precision Oncology|September 11, 2020
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung CancerSebastian Michels, Carina Heydt, Bianca van Veggel, et al.
Pneumologie (Stuttgart, Germany)|October 26, 2023
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, et al.
International Journal of Molecular Sciences|April 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy AnalysisOliver Illini, Felix Carl Saalfeld, Petros Christopoulos, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 19